These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Retraction: Curcumin Exerts Effects on the Pathophysiology of Alzheimer's Disease by Regulating PI(3,5)P2 and Transient Receptor Potential Mucolipin-1 Expression. Frontiers Editorial Office Front Neurol; 2019; 10():255. PubMed ID: 30873112 [TBL] [Abstract][Full Text] [Related]
6. Retraction: Mechanisms Contributing to the Generation of Mayer Waves. Frontiers Editorial Office Front Neurosci; 2021; 15():793064. PubMed ID: 34790094 [TBL] [Abstract][Full Text] [Related]
7. Retraction: Multiple sclerosis recognition by biorthogonal wavelet features and fitness-scaled adaptive genetic algorithm. Frontiers Editorial Office Front Neurosci; 2023; 17():1358300. PubMed ID: 38213657 [TBL] [Abstract][Full Text] [Related]
8. Testosterone-mediated neuroprotection through the androgen receptor in human primary neurons. Hammond J; Le Q; Goodyer C; Gelfand M; Trifiro M; LeBlanc A J Neurochem; 2001 Jun; 77(5):1319-26. PubMed ID: 11389183 [TBL] [Abstract][Full Text] [Related]
9. Retraction of "Isovitexin modulates autophagy in Alzheimer's disease via miR-107 signalling". Cheng J; Wang G; Zhang N; Li F; Shi L; Li H Transl Neurosci; 2022 Jan; 13(1):407. PubMed ID: 36447640 [TBL] [Abstract][Full Text] [Related]
10. Retraction: A deep learning model for three-dimensional nystagmus detection and its preliminary application. Frontiers Editorial Office Front Neurosci; 2023; 17():1358381. PubMed ID: 38213656 [TBL] [Abstract][Full Text] [Related]
11. Retraction of "Effect of C-phycocyanin on HDAC3 and miRNA-335 in Alzheimer's disease". Li Z; Gan L; Yan S; Yan Y; Huang W Transl Neurosci; 2024 Jan; 15(1):20220808. PubMed ID: 38841423 [TBL] [Abstract][Full Text] [Related]
12. Retraction: Resveratrol Preincubation Enhances the Therapeutic Efficacy of hUC-MSCs by Improving Cell Migration and Modulating Neuroinflammation Mediated by MAPK Signaling in a Mouse Model of Alzheimer's Disease. Frontiers Editorial Office Front Cell Neurosci; 2021; 15():728508. PubMed ID: 34366793 [TBL] [Abstract][Full Text] [Related]
13. Part of the interindividual variation in serum testosterone levels in healthy men reflects differences in androgen sensitivity and feedback set point: contribution of the androgen receptor polyglutamine tract polymorphism. Crabbe P; Bogaert V; De Bacquer D; Goemaere S; Zmierczak H; Kaufman JM J Clin Endocrinol Metab; 2007 Sep; 92(9):3604-10. PubMed ID: 17579205 [TBL] [Abstract][Full Text] [Related]
14. Retraction: Upregulation of C terminus of Hsc70-interacting protein attenuates apoptosis and procoagulant activity and facilitates brain repair after traumatic brain injury. Frontiers Editorial Office Front Neurosci; 2023; 17():1330870. PubMed ID: 38027479 [TBL] [Abstract][Full Text] [Related]
15. Retraction: ADVIAN: Alzheimer's disease VGG-inspired attention network based on convolutional block attention module and multiple way data augmentation. Frontiers Editorial Office Front Aging Neurosci; 2023; 15():1358292. PubMed ID: 38222263 [TBL] [Abstract][Full Text] [Related]
16. Androgen regulation of beta-amyloid protein and the risk of Alzheimer's disease. Rosario ER; Pike CJ Brain Res Rev; 2008 Mar; 57(2):444-53. PubMed ID: 17658612 [TBL] [Abstract][Full Text] [Related]
17. Association between androgen receptor gene CAG repeat polymorphism and plasma testosterone levels in postmenopausal women. Brum IS; Spritzer PM; Paris F; Maturana MA; Audran F; Sultan C J Soc Gynecol Investig; 2005 Feb; 12(2):135-41. PubMed ID: 15695110 [TBL] [Abstract][Full Text] [Related]
18. Up-regulation of hepatic alpha-2-HS-glycoprotein transcription by testosterone via androgen receptor activation. Voelkl J; Pakladok T; Lin Y; Viereck R; Lebedeva A; Kukuk D; Pichler BJ; Alesutan I; Lang F Cell Physiol Biochem; 2014; 33(6):1911-20. PubMed ID: 25011927 [TBL] [Abstract][Full Text] [Related]
19. Androgen deficiency and endothelial dysfunction in men with end-stage kidney disease receiving maintenance hemodialysis. Karakitsos D; Patrianakos AP; De Groot E; Boletis J; Karabinis A; Kyriazis J; Samonis G; Parthenakis FI; Vardas PE; Daphnis E Am J Nephrol; 2006; 26(6):536-43. PubMed ID: 17159341 [TBL] [Abstract][Full Text] [Related]
20. A pilot study on the effects of testosterone in hypogonadal aging male patients with Alzheimer's disease. Tan RS; Pu SJ Aging Male; 2003 Mar; 6(1):13-7. PubMed ID: 12809076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]